Cargando…

First Clinical Study with AP30663 ‐ a K(Ca)2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation

Pharmacological cardioversion of atrial fibrillation (AF) is frequently inefficacious. AP30663, a small conductance Ca(2+) activated K(+) (K(Ca)2) channel blocker, prolonged the atrial effective refractory period in preclinical studies and subsequently converted AF into normal sinus rhythm. This fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gal, Pim, Klaassen, Erica S., Bergmann, Kirsten R., Saghari, Mahdi, Burggraaf, Jacobus, Kemme, Michiel J. B., Sylvest, Christina, Sørensen, Ulrik, Bentzen, Bo H., Grunnet, Morten, Diness, Jonas G., Edvardsson, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719388/ https://www.ncbi.nlm.nih.gov/pubmed/32725783 http://dx.doi.org/10.1111/cts.12835

Ejemplares similares

The K(Ca)2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs
por: Diness, Jonas Goldin, et al.
Publicado: (2020)

Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man
por: Bentzen, Bo Hjorth, et al.
Publicado: (2020)

Inhibition of K(Ca)2 Channels Decreased the Risk of Ventricular Arrhythmia in the Guinea Pig Heart During Induced Hypokalemia
por: Diness, Jonas Goldin, et al.
Publicado: (2020)

Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy
por: Diness, Jonas G., et al.
Publicado: (2015)

Effect of short‐term fasting on electrocardiographic parameters
por: van der Stuijt, Willeke, et al.
Publicado: (2019)

The K(Ca)2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts
por: Kirchhoff, Jeppe Egedal, et al.
Publicado: (2019)

Inhibition of K(Ca)2 and K(v)11.1 Channels in Pigs With Left Ventricular Dysfunction
por: Citerni, Carlotta, et al.
Publicado: (2020)

Characterization of Atrial and Ventricular Structural Remodeling in a Porcine Model of Atrial Fibrillation Induced by Atrial Tachypacing
por: Citerni, Carlotta, et al.
Publicado: (2020)

A randomized controlled trial with a delayed‐type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man
por: Saghari, Mahdi, et al.
Publicado: (2020)

OX40L Inhibition Suppresses KLH‐driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof‐of‐Pharmacology for KY1005
por: Saghari, Mahdi, et al.
Publicado: (2022)

Impact of oral administration of single strain Lactococcus lactis spp. cremoris on immune responses to keyhole limpet hemocyanin immunization and gut microbiota: A randomized placebo-controlled trial in healthy volunteers
por: Saghari, Mahdi, et al.
Publicado: (2022)

The association between body temperature and electrocardiographic parameters in normothermic healthy volunteers
por: Fienieg, Bart, et al.
Publicado: (2020)

Letter to the Editor
por: Hassing, Gerardus J., et al.
Publicado: (2020)

Central and Peripheral GABA(A) Receptor Regulation of the Heart Rate Depends on the Conscious State of the Animal
por: Bentzen, Bo Hjorth, et al.
Publicado: (2011)

The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial
por: Grievink, Hendrika W., et al.
Publicado: (2020)

Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca(2+)-Activated K(+) Channels in Pigs
por: Diness, Jonas Goldin, et al.
Publicado: (2017)

Dose escalations in phase I studies: Feasibility of interpreting blinded pharmacodynamic data
por: Hassing, Gerardus J., et al.
Publicado: (2022)

Antiarrhythmic effect of the Ca(2+)-activated K(+) (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation
por: Kirchhoff, Jeppe Egedal, et al.
Publicado: (2016)

BK channel activators and their therapeutic perspectives
por: Bentzen, Bo H., et al.
Publicado: (2014)

Pharmacological inhibition of SK‐channels with AP14145 prevents atrial arrhythmogenic changes in a porcine model for obstructive respiratory events
por: Linz, Benedikt, et al.
Publicado: (2022)

Effective termination of atrial fibrillation by SK channel inhibition is associated with a sudden organization of fibrillatory conduction
por: Gatta, Giulia, et al.
Publicado: (2021)

Small conductance calcium activated K(+) channel inhibitor decreases stretch induced vulnerability to atrial fibrillation
por: Yan, Yannan, et al.
Publicado: (2021)

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?
por: in ‘t Veld, Aliede E., et al.
Publicado: (2019)

Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists
por: Birkhoff, Willem A. J., et al.
Publicado: (2018)

Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial
por: Eveleens Maarse, Boukje C., et al.
Publicado: (2021)

PSB93#13 Conversion Booster Avancement AP; Milestone Novembre 93
por: Arruat, M, et al.
Publicado: (1993)

2,6-Bis(2-Benzimidazolyl)Pyridine (BBP) Is a Potent and Selective Inhibitor of Small Conductance Calcium-Activated Potassium (SK) Channels
por: Simó-Vicens, Rafel, et al.
Publicado: (2018)

A two-step deconvolution-analysis-informed population pharmacodynamic modeling approach for drugs targeting pulsatile endogenous compounds
por: van Esdonk, Michiel J., et al.
Publicado: (2017)

Model informed quantification of the feed‐forward stimulation of growth hormone by growth hormone‐releasing hormone
por: van Esdonk, Michiel J., et al.
Publicado: (2020)

Body mass index related electrocardiographic findings in healthy young individuals with a normal body mass index
por: Hassing, G. J., et al.
Publicado: (2019)

Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling
por: van Esdonk, Michiel J., et al.
Publicado: (2020)

Conditional expression of PfAP2-G for controlled massive sexual conversion in Plasmodium falciparum
por: Llorà-Batlle, Oriol, et al.
Publicado: (2020)

Trastuzumab Induces an Immediate, Transient Volume Increase in Humans: A Randomised Placebo-Controlled Trial
por: Reijers, Joannes A.A., et al.
Publicado: (2015)

Under‐representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database
por: Ruiter, Rikje, et al.
Publicado: (2019)

Antiarrhythmic and Electrophysiologic Effects of Flecainide on Acutely Induced Atrial Fibrillation in Healthy Horses
por: Haugaard, M.M., et al.
Publicado: (2014)

The mysterious diadenosine tetraphosphate (AP4A)
por: Zegarra, Victor, et al.
Publicado: (2023)

Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial
por: Rousel, Jannik, et al.
Publicado: (2023)

Remarkable Pharmacokinetics of Monoclonal Antibodies: A Quest for an Explanation
por: Reijers, Joannes A. A., et al.
Publicado: (2016)

Inhibition of Small-Conductance Calcium-Activated Potassium Current (I(K,Ca)) Leads to Differential Atrial Electrophysiological Effects in a Horse Model of Persistent Atrial Fibrillation
por: Fenner, Merle Friederike, et al.
Publicado: (2021)

The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption
por: Dijkmans, Anneke C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6k2o72t9qk51dj8ufni1l80d8t